Skip to main content
. 2017 Jan 13;7:40529. doi: 10.1038/srep40529

Figure 7.

Figure 7

The experimental results of (a) the real-time quantitative PCR for detecting the mRNA level of COX-1 in the platelet treated by the active ingredients, and (b) the total COX activity in the platelet treated by various chemicals, with the chemical concentrations indicating in the sample names. Significant difference with respect to the corresponding agonist group: **p < 0.01; ***p < 0.001.